» Articles » PMID: 15297375

Ets-1 Stimulates Platelet-derived Growth Factor A-chain Gene Transcription and Vascular Smooth Muscle Cell Growth Via Cooperative Interactions with Sp1

Overview
Journal Circ Res
Date 2004 Aug 7
PMID 15297375
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The platelet-derived growth factor (PDGF) family of ligands (composed of A-, B-, C-, and D-chains), potent mitogens, and chemoattractants for cells of mesenchymal origin has been implicated in numerous vascular pathologies involving smooth muscle cell (SMC) hyperplasia. Understanding the molecular mechanisms mediating PDGF transcription would provide new insights into strategies to control PDGF-dependent pathophysiologic processes. We demonstrated previously that PDGF-A expression is under the positive regulatory influence of Sp1, Sp3, and Egr-1 and is negatively controlled by GCF2, NF-1(X), and WT-1. In this article, we demonstrate that Ets-1 induces PDGF-A expression in primary rat aortic SMCs at the level of transcription and mRNA expression. Electrophoretic mobility shift, supershift, and mutational analyses revealed a functional role for the (-555)TTCC(-552) motif in the PDGF-A promoter that binds endogenous Ets-1. Chromatin immunoprecipitation analysis showed the interaction of endogenous and exogenous Ets-1 or glutathione S-transferase-tagged Ets-1, bearing only the DNA-binding domain with the authentic PDGF-A promoter. Conversely, dominant-negative mutant of Ets-1 blocked the promoter interaction of endogenous Ets-1. Overexpression of Ets-1 but not the mutant form of Ets-1 activates the PDGF-A promoter cooperatively with Sp1. Sp1, which interacts with Ets-1, failed to induce PDGF-A promoter-dependent expression if the promoter contained a site-specific mutation in this novel Ets-binding site. Small interfering RNA to Ets-1 and Sp1 blocked PDGF-BB- and serum-inducible PDGF-A expression. SMC growth was stimulated by Ets-1 and Sp1 separately and further increased by both factors together. Ets-1-inducible mitogenesis is blocked by antibodies neutralizing PDGF-A and involves activation of the PDGF alpha-receptor, which binds PDGF-A. These findings identify a functional cis-acting element for Ets-1 in the PDGF-A promoter and demonstrate that Sp1 and Ets-1 cooperatively activate PDGF-A transcription in vascular SMCs.

Citing Articles

Role of post-translational modifications of Sp1 in cancer: state of the art.

Sun X, Xiao C, Wang X, Wu S, Yang Z, Sui B Front Cell Dev Biol. 2024; 12:1412461.

PMID: 39228402 PMC: 11368732. DOI: 10.3389/fcell.2024.1412461.


ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.

Zhu Z, Guo Y, Liu Y, Ding R, Huang Z, Yu W Adv Sci (Weinh). 2023; 10(32):e2303378.

PMID: 37786278 PMC: 10646254. DOI: 10.1002/advs.202303378.


LRRFIP1 expression triggers platelet agglutination by enhancing αIIbβ3 expression.

Yin X, Liu P, Liu Y, Liu M, Fan W, Liu B Exp Ther Med. 2019; 18(1):269-277.

PMID: 31258662 PMC: 6566026. DOI: 10.3892/etm.2019.7571.


A deficiency in SUMOylation activity disrupts multiple pathways leading to neural tube and heart defects in Xenopus embryos.

Bertke M, Dubiak K, Cronin L, Zeng E, Huber P BMC Genomics. 2019; 20(1):386.

PMID: 31101013 PMC: 6525467. DOI: 10.1186/s12864-019-5773-3.


Discovery of Novel Human Gene Regulatory Modules from Gene Co-expression and Promoter Motif Analysis.

Ma S, Snyder M, Dinesh-Kumar S Sci Rep. 2017; 7(1):5557.

PMID: 28717181 PMC: 5514134. DOI: 10.1038/s41598-017-05705-2.